Virataz R Tab

Virataz R Tab is a potent antiretroviral therapy used in the management of HIV-1 infection in adults and adolescents. This combination contains Atazanavir, a protease inhibitor, and Ritonavir, a pharmacokinetic booster that enhances Atazanavir’s effectiveness. Together, they provide robust viral suppression, support immune function, and reduce the risk of HIV-related complications.

• Atazanavir 300 MG – Inhibits the HIV protease enzyme, preventing the virus from replicating. It is effective in lowering viral load and maintaining immune system function.

• Ritonavir 100 MG – Acts as a booster by increasing blood levels of Atazanavir, ensuring optimal antiviral activity with once-daily dosing.

This combination is often prescribed as part of Highly Active Antiretroviral Therapy (HAART) alongside other antiretroviral medications to maximize viral suppression and minimize drug resistance. By taking Atazanavir with Ritonavir, patients benefit from improved adherence, convenience, and sustained immune support, helping them maintain healthy CD4 counts and overall well-being.